Currently, there are 225.56M common shares owned by the public and among those 222.47M shares have been available to trade.
The company’s stock has a 5-day price change of -1.57% and -18.34% over the past three months. HOLX shares are trading -21.02% year to date (YTD), with the 12-month market performance down to -24.00% lower. It has a 12-month low price of $55.89 and touched a high of $84.67 over the same period. HOLX has an average intraday trading volume of 2.76 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.77%, -7.92%, and -22.91% respectively.
Institutional ownership of Hologic, Inc (NASDAQ: HOLX) shares accounts for 103.38% of the company’s 225.56M shares outstanding.
It has a market capitalization of $12.78B and a beta (3y monthly) value of 0.56. The stock’s trailing 12-month PE ratio is 18.02, while the earnings-per-share (ttm) stands at $3.16. The company has a PEG of 2.34 and a Quick Ratio of 2.78 with the debt-to-equity ratio at 0.53. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.74% over the week and 3.14% over the month.
Analysts forecast that Hologic, Inc (HOLX) will achieve an EPS of 1.02 for the current quarter, 1.1 for the next quarter and 4.62 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 1.0 while analysts give the company a high EPS estimate of 1.0. Comparatively, EPS for the current quarter was 1.03 a year ago. Earnings per share for the fiscal year are expected to increase by 4.48%, and 8.72% over the next financial year.
Leerink Partners coverage for the Hologic, Inc (HOLX) stock in a research note released on February 06, 2025 offered a Market Perform rating with a price target of $75. Needham on their part issued Buy rating on December 10, 2024.
